- Home
- TGTX vs BLDEW Comparison
TGTX vs BLDEW Comparison
Compare TGTX & BLDEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TGTX
- BLDEW
- Stock Information
- Founded
- TGTX 1993
- BLDEW 2014
- Country
- TGTX United States
- BLDEW United States
- Employees
- TGTX N/A
- BLDEW 281
- Industry
- TGTX Biotechnology: Pharmaceutical Preparations
- BLDEW Transportation Services
- Sector
- TGTX Health Care
- BLDEW Consumer Discretionary
- Exchange
- TGTX Nasdaq
- BLDEW Nasdaq
- Market Cap
- TGTX N/A
- BLDEW N/A
- IPO Year
- TGTX 1995
- BLDEW N/A
- Fundamental
- Price
- TGTX $38.32
- BLDEW $0.14
- Analyst Decision
- TGTX Strong Buy
- BLDEW
- Analyst Count
- TGTX 6
- BLDEW 0
- Target Price
- TGTX $40.67
- BLDEW N/A
- AVG Volume (30 Days)
- TGTX 2.9M
- BLDEW 51.0K
- Earning Date
- TGTX 04-30-2025
- BLDEW 03-13-2025
- Dividend Yield
- TGTX N/A
- BLDEW N/A
- EPS Growth
- TGTX 68.03
- BLDEW N/A
- EPS
- TGTX 0.15
- BLDEW N/A
- Revenue
- TGTX $329,004,000.00
- BLDEW $241,814,000.00
- Revenue This Year
- TGTX $75.63
- BLDEW N/A
- Revenue Next Year
- TGTX $38.17
- BLDEW N/A
- P/E Ratio
- TGTX $255.47
- BLDEW N/A
- Revenue Growth
- TGTX 40.80
- BLDEW 12.04
- 52 Week Low
- TGTX $12.93
- BLDEW $0.30
- 52 Week High
- TGTX $43.32
- BLDEW $0.36
- Technical
- Relative Strength Index (RSI)
- TGTX 52.13
- BLDEW N/A
- Support Level
- TGTX $37.32
- BLDEW N/A
- Resistance Level
- TGTX $39.18
- BLDEW N/A
- Average True Range (ATR)
- TGTX 2.92
- BLDEW 0.00
- MACD
- TGTX -0.21
- BLDEW 0.00
- Stochastic Oscillator
- TGTX 66.29
- BLDEW 0.00
About BLDEW Blade Air Mobility Inc.
Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.